Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Familial Hypercholesterolemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03747224
What this trial is testing

Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients

Who this might be right for
DyslipidemiasFamilial HypercholesterolemiaHypertriglyceridemia
Arrowhead Pharmaceuticals 93
Not applicableNot Yet RecruitingNCT07653555
What this trial is testing

Cascade Testing In Identifying At-risk Family Members Of Individuals With Familial Hypercholesterolemia (FH) In PCP

Who this might be right for
Familial Hypercholesterolemia
Mayo Clinic 480
Not applicableStudy completedNCT01107743
What this trial is testing

Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Who this might be right for
HypertensionAngina PectorisHypercholesterolemia+1 more
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1,291
Not applicableStudy completedNCT02462655
What this trial is testing

Effects of LDL Apheresis System on the Expression of Genes Involved in Lipoprotein Metabolism and Inflammation in Homozygotes for Familial Hypercholesterolemia

Who this might be right for
Familial Hypercholesterolemia
Laval University 9
Not applicableActive Not RecruitingNCT05758779
What this trial is testing

The Danish Familial Hypercholesterolemia Organized Coronary Screening Trial

Who this might be right for
Familial HypercholesterolemiaAtherosclerosis
Odense University Hospital 100
Large-scale testing (Phase 3)Ended earlyNCT00151788
What this trial is testing

Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Carotid Artery Disease. This Study is Also Known as CAPTIVATE.

Who this might be right for
AtherosclerosisHeterozygous Familial Hypercholesterolemia
Daiichi Sankyo 796
Testing effectiveness (Phase 2)Study completedNCT01412034
What this trial is testing

Effect of CER-001 on Plaque Volume in Homozygous Familial Hypercholesterolemia (HoFH) Subjects

Who this might be right for
Homozygous Familial Hypercholesterolemia
Cerenis Therapeutics, SA 23
Testing effectiveness (Phase 2)Study completedNCT00280995
What this trial is testing

Dose-escalating Safety Study of ISIS 301012 in Homozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy

Who this might be right for
Hypercholesterolemia, Familial
Kastle Therapeutics, LLC 12
Large-scale testing (Phase 3)Study completedNCT03851705
What this trial is testing

Inclisiran in Participants With Homozygous Familial Hypercholesterolemia (HoFH)

Who this might be right for
Homozygous Familial Hypercholesterolemia
Novartis Pharmaceuticals 56
Not applicableStudy completedNCT01070966
What this trial is testing

Vytorin Reexamination Study (0653A-174)

Who this might be right for
Primary Hypercholesterolemia and Homozygous Familial Hypercholesterolemia (HoFH)
Organon and Co 2,089
Large-scale testing (Phase 3)Active Not RecruitingNCT07037771
What this trial is testing

Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)

Who this might be right for
Homozygous Familial Hypercholesterolemia
Arrowhead Pharmaceuticals 70
Not applicableStudy completedNCT00704444
What this trial is testing

A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)

Who this might be right for
HypercholesterolemiaFamilial HypercholesterolemiaHomozygous Sitosterolemia
Organon and Co 11,332
Large-scale testing (Phase 3)Not Yet RecruitingNCT07421284
What this trial is testing

Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy

Who this might be right for
Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 900
Early research (Phase 1)Ended earlyNCT01583647
What this trial is testing

Extended-release (ER) Niacin/Laropiprant in Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0524A-158)

Who this might be right for
Hypercholesterolemia, FamilialHeterozygous Familial Hypercholesterolemia
Merck Sharp & Dohme LLC 10
Not applicableStudy completedNCT02808403
What this trial is testing

Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan

Who this might be right for
HypercholesterolemiaFamilial Hypercholesterolemia
Amgen 6,000
Early research (Phase 1)Study completedNCT00739999
What this trial is testing

8-Week PK/PD Atorvastatin Study In Children And Adolescents With Heterozygous Familial Hypercholesterolemia

Who this might be right for
Pediatric Heterozygous Hypercholesterolemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 39
Not applicableStudy completedNCT04494464
What this trial is testing

Treatment Rates and Compliance to Treatment in Patients With Familial Hypercholesterolemia

Who this might be right for
Familial Hypercholesterolemia
Ankara Yildirim Beyazıt University 367
Large-scale testing (Phase 3)Study completedNCT02173158
What this trial is testing

Efficacy and Safety of Lomitapide in Japanese Patients With HoFH on Concurrent Lipid-Lowering Therapy

Who this might be right for
Familial Hypercholesterolemia - Homozygous
Aegerion Pharmaceuticals, Inc. 9
Early research (Phase 1)Looking for participantsNCT07491172
What this trial is testing

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

Who this might be right for
CardiovascularMetabolic DiseaseDyslipidemias+7 more
CRISPR Therapeutics AG 90
Not applicableUnknownNCT03152656
What this trial is testing

A Registration Study for Familial Hypercholesterolemia in Taiwan

Who this might be right for
Familial Hypercholesterolemia
National Taiwan University Hospital 1,000
Next Page